This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Janssen Pharmaceuticals, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Mahesh Narain Samtani: Innovator in Psychiatric Treatment
Introduction
Mahesh Narain Samtani is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of psychiatric treatment through his innovative approaches. With a focus on improving patient care, he has developed a unique method that addresses the challenges faced by patients undergoing long-acting injectable treatments.
Latest Patents
One of Mahesh Narain Samtani's key patents is titled "Dosing regimen for missed doses for long-acting injectable paliperidone esters." This patent provides a method for treating patients who are in need of psychiatric treatment but have missed their scheduled doses of the 3-month formulation of paliperidone palmitate. This innovation is crucial for ensuring that patients receive the necessary care even when they fail to adhere to their treatment schedule. He holds 1 patent in this area.
Career Highlights
Throughout his career, Mahesh has worked with prominent companies in the pharmaceutical industry, including Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica NV. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in psychiatric medication.
Collaborations
Mahesh has collaborated with several professionals in his field, including Paulien Gerarda Maria Ravenstijn and Srihari Gopal. These collaborations have further enhanced his work and have led to the development of effective treatment methodologies.
Conclusion
Mahesh Narain Samtani is a distinguished inventor whose work in psychiatric treatment has made a significant impact. His innovative patent addresses critical issues in patient care, showcasing his commitment to improving mental health treatment. His contributions continue to influence the pharmaceutical industry and enhance the lives of patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile